Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • GB1
    Junior Member
    • Apr 2017
    • 1

    #1

    MEDIPS DMR identification

    Hi

    I am trying to analyse some MeDIP-seq data using MEDIPS. I would like to perform differential methylation analysis between controls (C57_data) and a mutant sample (gtgt_data). I have attempted to do this using:

    results_C57_vs_gtgt=MEDIPS.meth(MSet1 = C57_data, MSet2 = gtgt_data,
    + CSet = CS, p.adj = "bonferroni", diff.method = "edgeR", MeDIP = T, CNV = F)

    However, I get the following error message:

    Error in MEDIPS.calibrationCurve(MSet = MSet1[[i]], CSet = CSet, input = F) :
    The dependency of coverage signals on sequence pattern (e.g. CpG) densities is different than expected. No linear model can be build, please check the calibration plot by providing the MSet object at ISet.

    I have attempted to plot the calibration plot, but get a similar error.

    I understand that the failure to build a proper linear model may be because there is not a linear dependency of CpG density and MeDIP-seq signal in my data.

    I do not have input data for either control or mutant sample.

    Is there a way to perform the differential methylation analysis on my data using MEDIPS despite this?

    Any help would be much appreciated

    Many thanks

    G

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...